B-Cell autophagy in diabetes pathogenesis

Michelle R. Marasco, Amelia Linnemann

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Nearly 100 years have passed since Frederick Banting and Charles Best first discovered and purified insulin. Their discovery and subsequent improvements revolutionized the treatment of diabetes, and the field continues to move at an ever-faster pace with respect to unique treatments for both type 1 and type 2 diabetes. Despite these advances, we still do not fully understand how apoptosis of the insulin-producing b-cells is triggered, presenting a challenge in the development of preventative measures. In recent years, the process of autophagy has generated substantial interest in this realm due to discoveries highlighting its clear role in the maintenance of cellular homeostasis. As a result, the number of studies focused on islet and b-cell autophagy has increased substantially in recent years. In this review, we will discuss what is currently known regarding the role of b-cell autophagy in type 1 and type 2 diabetes pathogenesis, with an emphasis on new and exciting developments over the past 5 years. Further, we will discuss how these discoveries might be translated into unique treatments in the coming years.

Original languageEnglish (US)
Pages (from-to)2127-2141
Number of pages15
JournalEndocrinology
Volume159
Issue number5
DOIs
StatePublished - May 1 2018

Fingerprint

Autophagy
B-Lymphocytes
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Insulin
Islets of Langerhans
Homeostasis
Maintenance
Apoptosis

ASJC Scopus subject areas

  • Endocrinology

Cite this

B-Cell autophagy in diabetes pathogenesis. / Marasco, Michelle R.; Linnemann, Amelia.

In: Endocrinology, Vol. 159, No. 5, 01.05.2018, p. 2127-2141.

Research output: Contribution to journalReview article

Marasco, Michelle R. ; Linnemann, Amelia. / B-Cell autophagy in diabetes pathogenesis. In: Endocrinology. 2018 ; Vol. 159, No. 5. pp. 2127-2141.
@article{1a9e87bebbf74700b76de436df37c2c3,
title = "B-Cell autophagy in diabetes pathogenesis",
abstract = "Nearly 100 years have passed since Frederick Banting and Charles Best first discovered and purified insulin. Their discovery and subsequent improvements revolutionized the treatment of diabetes, and the field continues to move at an ever-faster pace with respect to unique treatments for both type 1 and type 2 diabetes. Despite these advances, we still do not fully understand how apoptosis of the insulin-producing b-cells is triggered, presenting a challenge in the development of preventative measures. In recent years, the process of autophagy has generated substantial interest in this realm due to discoveries highlighting its clear role in the maintenance of cellular homeostasis. As a result, the number of studies focused on islet and b-cell autophagy has increased substantially in recent years. In this review, we will discuss what is currently known regarding the role of b-cell autophagy in type 1 and type 2 diabetes pathogenesis, with an emphasis on new and exciting developments over the past 5 years. Further, we will discuss how these discoveries might be translated into unique treatments in the coming years.",
author = "Marasco, {Michelle R.} and Amelia Linnemann",
year = "2018",
month = "5",
day = "1",
doi = "10.1210/en.2017-03273",
language = "English (US)",
volume = "159",
pages = "2127--2141",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - B-Cell autophagy in diabetes pathogenesis

AU - Marasco, Michelle R.

AU - Linnemann, Amelia

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Nearly 100 years have passed since Frederick Banting and Charles Best first discovered and purified insulin. Their discovery and subsequent improvements revolutionized the treatment of diabetes, and the field continues to move at an ever-faster pace with respect to unique treatments for both type 1 and type 2 diabetes. Despite these advances, we still do not fully understand how apoptosis of the insulin-producing b-cells is triggered, presenting a challenge in the development of preventative measures. In recent years, the process of autophagy has generated substantial interest in this realm due to discoveries highlighting its clear role in the maintenance of cellular homeostasis. As a result, the number of studies focused on islet and b-cell autophagy has increased substantially in recent years. In this review, we will discuss what is currently known regarding the role of b-cell autophagy in type 1 and type 2 diabetes pathogenesis, with an emphasis on new and exciting developments over the past 5 years. Further, we will discuss how these discoveries might be translated into unique treatments in the coming years.

AB - Nearly 100 years have passed since Frederick Banting and Charles Best first discovered and purified insulin. Their discovery and subsequent improvements revolutionized the treatment of diabetes, and the field continues to move at an ever-faster pace with respect to unique treatments for both type 1 and type 2 diabetes. Despite these advances, we still do not fully understand how apoptosis of the insulin-producing b-cells is triggered, presenting a challenge in the development of preventative measures. In recent years, the process of autophagy has generated substantial interest in this realm due to discoveries highlighting its clear role in the maintenance of cellular homeostasis. As a result, the number of studies focused on islet and b-cell autophagy has increased substantially in recent years. In this review, we will discuss what is currently known regarding the role of b-cell autophagy in type 1 and type 2 diabetes pathogenesis, with an emphasis on new and exciting developments over the past 5 years. Further, we will discuss how these discoveries might be translated into unique treatments in the coming years.

UR - http://www.scopus.com/inward/record.url?scp=85052079021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052079021&partnerID=8YFLogxK

U2 - 10.1210/en.2017-03273

DO - 10.1210/en.2017-03273

M3 - Review article

VL - 159

SP - 2127

EP - 2141

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 5

ER -